在患有严重过敏喘的患者中Omalizumab的实际有效性:RELIEF研究
Mona Al Ahmad1, Lilia Margarita Borboa Olivares2, Alexandre Pinto Cardoso3
1Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait.
The open respiratory medicine journal
|June 5, 2023
概括
在严重过敏性喘患者中,omalizumab补充疗法显著减少了恶化和医疗保健使用. 现实生活数据显示,24个月的喘控制和治疗效率有所改善.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 肺部病理学 肺部病理学
- 临床治疗学 临床治疗学
背景情况:
- 严重过敏性喘 (SAA) 具有严重的恶化风险.
- 尽管接受标准治疗,但奥马利祖马布是未经控制的SAA的推补充剂.
- 在RELIEF研究中,对SAA的真实世界奥马利祖马布疗效进行了评估.
研究的目的:
- 评估奥马利祖马布作为SAA患者的附加治疗的现实有效性.
- 为了评估24个月的恶化,医疗资源利用和喘控制的变化.
主要方法:
- 展望性,开放标签,多中心研究.
- 纳入347名年龄≥6岁的SAA患者;285人完成了24个月.
- 收集了有关恶化,医疗保健访问,喘控制测试和治疗有效性的全球评估 (GETE) 的数据.
主要成果:
- 与基线相比,恶化的平均数量减少.
- 没有恶化的患者比例增加 (77.7%在24个月).
- 减少医疗保健资源的利用,包括专家访问 (5.8至2.4).
- 改善了喘控制测试分数 (>19) 和GETE分数.
- 肺功能稳定,没有新的安全问题.
结论:
- 奥马利祖马布补充疗法在减少SAA恶化方面是有效的.
- 它改善了医疗保健利用率和控制了标准治疗无法控制的患者的喘.
- 现实世界的证据支持奥马利祖马布在SAA管理中的作用.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
358
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
358
Antiasthma Drugs: Leukotriene Modifiers
375
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
375
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management
462
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
462
Antiasthma Drugs: β2-Adrenoceptor Agonists
318
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
318


